FrancophonIA/ELRC3.0 huggingface dataset:
English: The solution for injection contains the active substance follitropin beta, produced by genetic engineering of a Chinese hamster ovary (CHO) cell line.
Slovenian: Raztopina za injiciranje vsebuje zdravilno učinkovino folitropin beta, pridobljeno s pomočjo genetskega inženiringa z uporabo ovarijskih celic kitajskega hrčka (Chinese hamster ovary, CHO).
English: Subcutaneous injection of Puregon may be carried out by patient or partner, provided that proper instructions are given by the physician.
Slovenian: Subkutane injekcije zdravila Puregon si lahko dajejo bolniki sami, ali jim jih dajejo njihovi partnerji, če jih zdravnik pred tem ustrezno pouči.
English: When using a GnRH agonist, a higher total treatment dose of Puregon may be required to achieve an adequate follicular response.
Slovenian: Pri uporabi agonista GnRh bo morda potreben večji odmerek zdravila Puregon za ustrezen folikularni odziv.
English: Furthermore Puregon can be used to promote multiple follicular development in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intrafallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)].
Slovenian: Zdravilo Puregon se uporablja tudi za pospeševanje razvoja večih foliklov pri programih oploditve z biomedicinsko pomočjo (npr. pri zunajtelesni oploditvi/prenosu zarodka (IVF/ET), prenosu gamete v jajcevod (GIFT) in pri intracitoplazemski injekciji sperme (ICSI)).
English: Puregon solution for injection in cartridges has been developed for use in the Puregon Pen and should be administered subcutaneously.
Slovenian: Puregon raztopina za injiciranje v vložkih je bila razvita za uporabo v peresniku Puregon Pen in se uporablja subkutano.
English: Puregon solution for injection comes in a glass vial.
Slovenian: Raztopina za injiciranje Puregon je v stekleni viali.
English: For controlled ovarian stimulation, Puregon resulted in a higher number of oocytes retrieved at a lower total dose and with a shorter treatment period, when compared to urinary FSH.
Slovenian: Pri nadzorovani stimulaciji jajčnikov so z zdravilom Puregon dosegli večje število zbranih jajčec ob manjšem celotnem odmerku in v krajšem obdobju zdravljenja kot pri urinskem FSH.
English: If a GnRH agonist (a medicine used to prevent early ovulation) has been given, higher doses of Puregon may be needed.
Slovenian: Če pa sočasno prejemate agonist GnRH (zdravilo za preprečevanje prezgodnje ovulacije), boste lahko potrebovali večje odmerke zdravila Puregon.
English: Puregon may affect milk production.
Slovenian: Zdravilo Puregon lahko vpliva na nastajanje materinega mleka.
English: The solution for injection contains the active substance follitropin beta, produced by genetic engineering of a Chinese hamster ovary (CHO) cell line, in a concentration of 833 IU/mL aqueous solution.
Slovenian: Raztopina za injiciranje vsebuje zdravilno učinkovino folitropin beta, pridobljeno s pomočjo genetskega inženiringa z uporabo ovarijskih celic kitajskega hrčka (Chinese hamster ovary, CHO), v koncentraciji 833 i.e./ml vodne raztopine.
English: • Each cartridge contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH) in a strength of 833 IU/mL aqueous solution.
Slovenian: • En vložek vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan pod imenom folikle stimulirajoči hormon (FSH), z jakostjo 833 i.e./ml vodne raztopine.
English: Puregon treatment is then stopped and ovulation will be induced by giving human chorionic gonadotrophin (hCG).
Slovenian: Takrat zdravljenje z zdravilom Puregon prekinemo in sprožimo ovulacijo z dajanjem humanega horionskega gonadotropina (hCG).
English: For ovulation induction, Puregon resulted in a lower median total dose and shorter median duration of treatment when compared to urinary FSH.
Slovenian: Pri indukciji ovulacije je bil v skupini, ki je prejemala zdravilo Puregon, srednji celotni odmerek manjši, srednji čas trajanja zdravljenja pa krajši kot v skupini, ki je prejemala urinski FSH.
English: What Puregon contains
Slovenian: Kaj vsebuje zdravilo Puregon
English: Puregon solution for injection is designed for use in conjunction with the Puregon Pen.
Slovenian: Puregon raztopina za injiciranje je namenjena uporabi skupaj s peresnikom Puregon Pen.
English: 1025 IU recombinant FSH activity/1.230 mL Net content 900 IU
Slovenian: 1.025 i.e. aktivnosti rekombinantnega FSH/1,230 ml Neto vsebina 900 i.e.
English: Puregon showed no mutagenic potential in the Ames test and in the in vitro chromosome aberration test with human lymphocytes.
Slovenian: Amesov test in in vitro test kromosomskih aberacij s človeškimi limfociti nista pokazala mutagenih učinkov zdravila Puregon.
English: Multiple pregnancies and births have been reported for all gonadotropin treatments, including Puregon.
Slovenian: Med vsemi zdravljenji z gonadotropini, vključno z zdravilom Puregon, so poročali o večplodnih nosečnostih in rojstvih.
English: You should use sterile disposable syringes and needles for the administration of Puregon.
Slovenian: Za dajanje zdravila Puregon morate uporabljati sterilne brizge in igle za enkratno uporabo.
English: After pituitary desensitisation induced by a GnRH agonist, a higher dose of Puregon may be necessary to achieve an adequate follicular response.
Slovenian: Po desenzibilizaciji hipofize z agonistom GnRh bo za enak folikularni odziv morda potreben večji odmerek zdravila Puregon.
English: CARTRIDGE TEXT Puregon 300 IU/0.36 mL
Slovenian: BESEDILO NA VLOŽKU Puregon 300 i.e./0,36 ml
English: CARTRIDGE TEXT Puregon 900 IU/1.08 mL
Slovenian: BESEDILO NA VLOŽKU Puregon 900 i.e./1,08 ml
English: This dose may be adjusted during your treatment period.
Slovenian: Zdravnik vam bo določil začetni odmerek, ki ga bo lahko spreminjal med zdravljenjem.
English: CARTRIDGE TEXT Puregon 600 IU/0.72 mL
Slovenian: BESEDILO NA VLOŽKU Puregon 600 i.e./0,72 ml
English: Multiple gestation, especially high order, carries an increased risk of adverse maternal (pregnancy and delivery complications) and perinatal (low birth weight) outcomes.For anovulatory women undergoing ovulation induction, monitoring follicular development with transvaginal ultrasonography may aid in determining whether or not to continue the cycle in order to reduce the risk of multiple pregnancies.
Slovenian: Pri ženskah brez ovulacij, pri katerih poteka indukcija ovulacije, lahko spremljanje razvoja foliklov s transvaginalno ultrazvočno preiskavo pomaga pri odločitvi, ali naj se ciklus nadaljuje ali ne, da bi zmanjšali tveganje za večplodno nosečnost.
English: Women with known risk factors for a high ovarian response may be especially prone to the development of OHSS during or following treatment with Puregeon.
Slovenian: K nastanku OHSS med zdravljenjem z zdravilom Puregon ali po njem so lahko posebej nagnjene ženske z znanimi dejavniki tveganja za velik odziv jajčnikov.
English: Ovarian and Other Reproductive System Tumours There have been reports of ovarian and other reproductive system tumors in women who have had infertility treatment.
Slovenian: Tumorji na jajčnikih in drugih spolnih organih Pri ženskah, zdravljenih zaradi neplodnosti, so poročali o tumorjih na jajčnikih in drugih spolnih organih.
English: Other Medical Conditions
Slovenian: Druga bolezenska stanja
English: The contents of the vial should be used immediately after piercing of the rubber stopper.
Slovenian: Vsebino viale morate porabiti takoj, ko prebodete gumijasto zaporko.
English: Thromboembolic events, both in association with and separate from OHSS, have been reported following treatment with gonadotropins, including Puregon.
Slovenian: Po zdravljenju z gonadotropini, vključno z zdravilom Puregon, so poročali o trombemboličnih dogodkih, in sicer tako v povezavi z OHSS kot nepovezano z njim.
English: For males and females
Slovenian: Za ženske in moške
English: VIAL TEXT Puregon 225 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 225 i.e./0,5 ml
English: Keep the vial(s) in the outer carton.
Slovenian: Vialo (viale) shranjujte v zunanji ovojnini.
English: CARTRIDGE TEXT Puregon 150 IU/0.18 mL
Slovenian: BESEDILO NA VLOŽKU Puregon 150 i.e./0,18 ml
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection
Slovenian: Puregon 150 i.e./0,18 ml raztopina za injiciranje Puregon 300 i.e./0,36 ml raztopina za injiciranje Puregon 600 i.e./0,72 ml raztopina za injiciranje Puregon 900 i.e./1,08 ml raztopina za injiciranje
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection follitropin beta
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje Puregon 75 i.e./0,5 ml raztopina za injiciranje Puregon 100 i.e./0,5 ml raztopina za injiciranje Puregon 150 i.e./0,5 ml raztopina za injiciranje Puregon 200 i.e./0,5 ml raztopina za injiciranje Puregon 225 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: Puregon 300 IU/0.36 mL solution for injection
Slovenian: Puregon 300 i.e./0,36 ml raztopina za injiciranje
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje Puregon 75 i.e./0,5 ml raztopina za injiciranje Puregon 100 i.e./0,5 ml raztopina za injiciranje Puregon 150 i.e./0,5 ml raztopina za injiciranje Puregon 200 i.e./0,5 ml raztopina za injiciranje Puregon 225 i.e./0,5 ml raztopina za injiciranje
English: Puregon 600 IU/0.72 mL solution for injection
Slovenian: Puregon 600 i.e./0,72 ml raztopina za injiciranje
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection follitropin beta
Slovenian: Puregon 150 i.e./0,18 ml raztopina za injiciranje Puregon 300 i.e./0,36 ml raztopina za injiciranje Puregon 600 i.e./0,72 ml raztopina za injiciranje Puregon 900 i.e./1,08 ml raztopina za injiciranje folitropin beta
English: Puregon 900 IU/1.08 mL solution for injection
Slovenian: Puregon 900 i.e./1,08 ml raztopina za injiciranje
English: OUTER CARTON TEXT Puregon 900 IU/1.08 mL 1 cartridge
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 900 i.e./1,08 ml 1 vložek
English: Puregon contains a recombinant FSH.
Slovenian: Zdravilo Puregon vsebuje rekombinantni FSH, ki ga pridobivajo s tehnologijo rekombinantne DNK.
English: Ovarian torsion has been reported after treatment with gonadotropins, including Puregon.
Slovenian: Po zdravljenju z gonadotropini, vključno z zdravilom Puregon, so poročali o torziji jajčnikov.
English: Puregon solution for injection in cartridges has been developed for use in the Puregon Pen.
Slovenian: Puregon raztopina za injiciranje v vložkih je namenjena za uporabo s peresnikom Puregon Pen.
English: Talk to your doctor before using Puregon if you:
Slovenian: Pred začetkom uporabe zdravila Puregon se posvetujte z zdravnikom:
English: OUTER CARTON TEXT Puregon 300 IU/0.36 mL 1 cartridge
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 300 i.e./0,36 ml 1 vložek
English: Intramuscular (IM) and subcutaneous (SC) use.
Slovenian: intramuskularna (i.m.)
English: OUTER CARTON TEXT Puregon 600 IU/0.72 mL 1 cartridge
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 600 i.e./0,72 ml 1 vložek
English: Puregon 225 IU/0.5 mL solution for injection
Slovenian: Puregon 225 i.e./0,5 ml raztopina za injiciranje
English: Ovarian torsion has occurred after treatment with gonadotropins including Puregon.
Slovenian: Med zdravljenjem z gonadotropini, vključno z zdravilom Puregon, so se pojavili primeri torzije jajčnikov.
English: Puregon 300 IU/0.36 mL injection follitropin beta
Slovenian: Puregon 300 i.e./0,36 ml injekcija folitropin beta s.c.
English: Puregon 300 IU/0.36 mL solution for injection EU/1/96/008/038
Slovenian: Puregon 300 i.e./0,36 ml raztopina za injiciranje EU/1/96/008/038
English: Puregon 600 IU/0.72 mL injection follitropin beta
Slovenian: Puregon 600 i.e./0,72 ml injekcija folitropin beta s.c.
English: Do not mix any other drug into the cartridges.Empty cartridges must not be refilled.
Slovenian: V vložku ne smete mešati nobenega drugega zdravila.
English: VIAL TEXT Puregon 75 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 75 i.e./0,5 ml
English: How to store Puregon
Slovenian: Shranjevanje zdravila Puregon
English: Puregon 150 IU/0.18 mL solution for injection EU/1/96/008/040
Slovenian: Puregon 150 i.e./0,18 ml raztopina za injiciranje EU/1/96/008/040
English: Puregon 150 IU/0.18 mL solution for injection
Slovenian: Puregon 150 i.e./0,18 ml raztopina za injiciranje
English: Puregon 75 IU/0.5 mL solution for injection
Slovenian: Puregon 75 i.e./0,5 ml raztopina za injiciranje
English: OUTER CARTON TEXT Puregon 150 IU/0.18 mL 1 cartridge
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 150 i.e./0,18 ml 1 vložek
English: OUTER CARTON TEXT Puregon 225 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 225 i.e./0,5 ml 1, 5 ali 10 vial
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 225 IU (450 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Slovenian: 1 viala vsebuje 0,5 ml folitropina beta, ki ustreza: 225 i.e. (450 i.e./ml) aktivnosti rekombinantnega folikle stimulirajočega hormona (FSH).
English: For use only with the Puregon Pen.
Slovenian: subkutana (s.c.) uporaba Za uporabo le s peresnikom Puregon Pen.
English: Puregon 600 IU/0.72 mL solution for injection EU/1/96/008/039
Slovenian: Puregon 600 i.e./0,72 ml raztopina za injiciranje EU/1/96/008/039
English: Puregon 150 IU/0.18 mL injection follitropin beta
Slovenian: Puregon 150 i.e./0,18 ml injekcija folitropin beta s.c.
English: VIAL TEXT Puregon 200 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 200 i.e./0,5 ml
English: Puregon 900 IU/1.08 mL solution for injection EU/1/96/008/041
Slovenian: Puregon 900 i.e./1,08 ml raztopina za injiciranje EU/1/96/008/041
English: OUTER CARTON TEXT Puregon 75 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 75 i.e./0,5 ml 1, 5 ali 10 vial
English: Puregon 225 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 225 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: The concurrent determination of serum oestradiol levels may also be useful.The patients should be advised of the potential risks of multiple births before starting treatment.
Slovenian: Pred začetkom zdravljenja ženske poučite o potencialnih tveganjih večplodne nosečnosti.
English: Puregon 75 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 75 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: Treatment with Puregon and hCG should be continued for at least 3 to 4 months before any improvement in spermatogenesis can be expected.
Slovenian: Moškim dajte 450 i.e. zdravila Puregon na teden, najbolje v 3 odmerkih po 150 i.e., skupaj s hCG. Zdravljenje z zdravilom Puregon in hCG mora trajati najmanj 3 do 4 mesece, preden lahko pričakujete izboljšanje spermatogeneze.
English: Puregon 225 IU/0.5 mL solution for injection EU/1/96/008/032
Slovenian: Puregon 225 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/032
English: Puregon 200 IU/0.5 mL solution for injection EU/1/96/008/029
Slovenian: Puregon 200 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/029
English: VIAL TEXT Puregon 50 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 50 i.e./0,5 ml
English: Puregon 900 IU/1.08 mL injection follitropin beta
Slovenian: Puregon 900 i.e./1,08 ml injekcija folitropin beta s.c.
English: One vial contains 22.5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Slovenian: Ena viala vsebuje 22,5 mikrogramov beljakovin (specifična biološka aktivnost in vivo ustreza približno 10.000 i.e. FSH / mg beljakovin).
English: After intramuscular or subcutaneous administration of Puregon, maximum concentrations of FSH are reached within about 12 hours.
Slovenian: Največje koncentracije FSH so dosežene približno 12 ur po intramuskularnem ali subkutanem dajanju zdravila Puregon.
English: Puregon 200 IU/0.5 mL solution for injection
Slovenian: Puregon 200 i.e./0,5 ml raztopina za injiciranje
English: One vial contains 225 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Slovenian: Ena viala vsebuje 225 i.e. rekombinantnega folikle stimulirajočega hormona (FSH) v 0,5 ml vodne raztopine, kar ustreza 450 i.e./ml.
English: Puregon 100 IU/0.5 mL solution for injection EU/1/96/008/023
Slovenian: Puregon 100 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/023
English: Puregon 75 IU/0.5 mL solution for injection EU/1/96/008/020
Slovenian: Puregon 75 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/020
English: Puregon 150 IU/0.5 mL solution for injection
Slovenian: Puregon 150 i.e./0,5 ml raztopina za injiciranje
English: Puregon 300 IU/0.36 mL solution for injection follitropin beta
Slovenian: Puregon 300 i.e./0,36 ml raztopina za injiciranje folitropin beta
English: Puregon 150 IU/0.5 mL solution for injection EU/1/96/008/026
Slovenian: Puregon 150 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/026
English: VIAL TEXT Puregon 100 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 100 i.e./0,5 ml
English: OUTER CARTON TEXT Puregon 150 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 150 i.e./0,5 ml 1, 5 ali 10 vial
English: Puregon 50 IU/0.5 mL solution for injection EU/1/96/008/017
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje EU/1/96/008/017
English: One vial contains 7.5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Slovenian: Ena viala vsebuje 7,5 mikrogramov beljakovin (specifična biološka aktivnost in vivo ustreza približno 10.000 i.e. FSH / mg beljakovin).
English: Puregon 225 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 225 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 225 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: OUTER CARTON TEXT Puregon 200 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 200 i.e./0,5 ml 1, 5 ali 10 vial
English: Puregon 200 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 200 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: OUTER CARTON TEXT Puregon 50 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 50 i.e./0,5 ml 1, 5 ali 10 vial
English: Puregon 50 IU/0.5 mL solution for injection
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje
English: Puregon 100 IU/0.5 mL solution for injection
Slovenian: Puregon 100 i.e./0,5 ml raztopina za injiciranje
English: Puregon 50 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: Puregon 75 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 75 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 75 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: OUTER CARTON TEXT Puregon 100 IU/0.5 mL 1, 5 or 10 vials
Slovenian: BESEDILO NA ZUNANJI OVOJNINI Puregon 100 i.e./0,5 ml 1, 5 ali 10 vial
English: Puregon 600 IU/0.72 mL solution for injection follitropin beta
Slovenian: Puregon 600 i.e./0,72 ml raztopina za injiciranje folitropin beta
English: Puregon 150 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 150 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: Puregon 100 IU/0.5 mL injection follitropin beta
Slovenian: Puregon 100 i.e./0,5 ml raztopina za injiciranje folitropin beta
English: Puregon 150 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 150 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 150 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: Puregon 900 IU/1.08 mL solution for injection follitropin beta
Slovenian: Puregon 900 i.e./1,08 ml raztopina za injiciranje folitropin beta
English: Puregon 200 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 200 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 200 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: Puregon 100 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 100 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 100 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: Puregon 150 IU/0.18 mL solution for injection follitropin beta
Slovenian: Puregon 150 i.e./0,18 ml raztopina za injiciranje folitropin beta
English: VIAL TEXT Puregon 150 IU/0.5 mL
Slovenian: BESEDILO NA VIALI Puregon 150 i.e./0,5 ml
English: Puregon 50 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 50 IU in 0.5 mL aqueous solution per vial.
Slovenian: Puregon 50 i.e./0,5 ml raztopina za injiciranje: Ena viala vsebuje zdravilno učinkovino folitropin beta, hormon, ki je poznan kot folikle stimulirajoči hormon (FSH).
English: Puregon solution for injection contains:
Slovenian: Zdravilo Puregon raztopina za injiciranje vsebuje: saharozo natrijev citrat
English: NN:
Slovenian: N.V.
English: Further information on Rasilez HCT can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Nadaljnje informacije o zdravilu Rasilez HCT so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Overall, the company presented the results of nine main studies involving a total of almost 9,000 patients with essential hypertension.
Slovenian: Skupno je predstavilo rezultate devetih glavnih študij, v katere je bilo skupno vključenih skoraj 9 000 bolnikov z esencialno hipertenzijo.
English: Aliskiren on its own has been authorised in the EU since August 2007 as Rasilez, Sprimeo and Riprazo.
Slovenian: Aliskiren je v Evropski uniji (EU) kot samostojno zdravilo odobren od avgusta 2007 pod imeni Rasilez, Sprimeo in Riprazo.
English: Rasilez HCT received a marketing authorisation valid throughout the EU on 16 January 2009.
Slovenian: Za zdravilo Rasilez HCT je bilo 16. januarja 2009 izdano dovoljenje za promet, veljavno po vsej EU.
English: Rasilez HCT can only be obtained with a prescription and it is available as tablets (150 mg/12.5 mg; 150 mg/25 mg; 300 mg /12.5 mg; 300 mg/25 mg).The recommended dose of Rasilez HCT is one tablet per day.
Slovenian: Predpisovanje in izdaja zdravila Rasilez HCT je le na recept, zdravilo pa je na voljo v obliki tablet (150 mg/12,5 mg; 150 mg/25 mg; 300 mg /12,5 mg; 300 mg/25 mg).Priporočeni odmerek zdravila Rasilez HCT je ena tableta na dan. Odmerek je odvisen od odmerkov aliskirena ali hidroklorotiazida, ki ju je bolnik jemal prej.